- Home
- OCS vs MEGI Comparison
OCS vs MEGI Comparison
Compare OCS & MEGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCS
- MEGI
- Stock Information
- Founded
- OCS 2003
- MEGI 2021
- Country
- OCS Switzerland
- MEGI United States
- Employees
- OCS N/A
- MEGI N/A
- Industry
- OCS Biotechnology: Pharmaceutical Preparations
- MEGI Investment Managers
- Sector
- OCS Health Care
- MEGI Finance
- Exchange
- OCS Nasdaq
- MEGI Nasdaq
- Market Cap
- OCS 689.8M
- MEGI 689.1M
- IPO Year
- OCS N/A
- MEGI N/A
- Fundamental
- Price
- OCS $18.76
- MEGI $13.65
- Analyst Decision
- OCS Strong Buy
- MEGI
- Analyst Count
- OCS 4
- MEGI 0
- Target Price
- OCS $30.25
- MEGI N/A
- AVG Volume (30 Days)
- OCS 28.7K
- MEGI 178.0K
- Earning Date
- OCS 05-20-2025
- MEGI 01-01-0001
- Dividend Yield
- OCS N/A
- MEGI 11.40%
- EPS Growth
- OCS N/A
- MEGI N/A
- EPS
- OCS N/A
- MEGI N/A
- Revenue
- OCS $757,024.00
- MEGI N/A
- Revenue This Year
- OCS $49.27
- MEGI N/A
- Revenue Next Year
- OCS $1,920.31
- MEGI N/A
- P/E Ratio
- OCS N/A
- MEGI N/A
- Revenue Growth
- OCS N/A
- MEGI N/A
- 52 Week Low
- OCS $10.79
- MEGI $10.63
- 52 Week High
- OCS $23.08
- MEGI $14.89
- Technical
- Relative Strength Index (RSI)
- OCS 57.04
- MEGI 62.09
- Support Level
- OCS $18.01
- MEGI $13.32
- Resistance Level
- OCS $19.50
- MEGI $13.70
- Average True Range (ATR)
- OCS 0.72
- MEGI 0.22
- MACD
- OCS 0.18
- MEGI 0.05
- Stochastic Oscillator
- OCS 76.19
- MEGI 87.28
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund
MainStay CBRE Global Infrastructure Megatrends Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It invests predominantly in income-producing equity securities issued by infrastructure companies, including common stock, preferred stock, convertible securities, and rights or warrants to buy common stocks. The company intends to focus on three infrastructure megatrends: decarbonization, digital transformation, and asset modernization while making its investments.